An efficient and direct procedure for the synthesis of pyrrolo [2,3-d]pyrimidine-2,4-dione derivatives using controlled microwave heating has been described. The products were characterized by elemental analyses, IR, 1 H NMR, 13 C NMR and MS spectra.
Introduction
Fused pyrimidinone derivatives have attracted the attention of numerous researchers over many years due to their important biological activities [1 -3] . Among them, pyrrolo [2,3-d] pyrimidines, a class of 7-deazapurine analog, exhibit interesting biological activity in part due to their resemblance to pyrimidines and purines. For example, they have recently been reported as enzyme inhibitors [4] , cytotoxic [5] , antiinflammatory [6] , anti-microbial [6] , antibacterial [7] , antifungal [7] , anticancer [8] , antitumor [9] , antifolate [10] , antiviral [11] , vascular endothelial growth factor receptor-2 inhibitors [12] , and antiangiogenic agents [12] . They also possess anti-HCV, anti-HIV type 1, anti-HSV, adenosine kinase inhibition, Aurora-A kinase inhibition and cAMP phosphodiesterase inhibition activity [13 -15] .
Recently, we have reported a simple and efficient synthesis of pyrimido [5,4-b] quinoline-2,4,9-triones 3 [16] , 4 [17] and pyrido [3,2-d : 6,5 -d ]dipyrimidines 6 [18] via the reaction of 5-aminouracil (1), aldehydes and dimedone (2) or barbituric acid derivatives 5 under microwave irradiation without catalyst, which could have interesting effects on biological targets (Scheme 1).
Considering the above reports and in continuation of our interest in the development of new and sim-0932-0776 / 11 / 0800-0843 $ 06.00 c 2011 Verlag der Zeitschrift für Naturforschung, Tübingen · http://znaturforsch.com Scheme 1. Synthesis of pyrimido [5,4- ple methods for the synthesis of polyfunctionally substituted heterocyclic compounds [16 -28] , we wish to report a novel and efficient one-pot method for the synthesis of pyrrolo [2,3-d] pyrimidine-2,4-dione and pyrimido [5,4-b] quinoline-2,4,9-trione derivatives with expected interesting biological activity. 
Results and Discussion
Thus, 5-aminouracil (1), dimedone (2) and phenylglyoxal hydrate (7) in DMF gave under controlled microwave heating for 20 min at 160 • C a solid product of molecular formula C 20 H 19 N 3 O 4 (m/z = 365 (30 %) [M] + ) which may be formulated as the pyrrolo[2,3-d]-pyrimidine-2,4-dione 10 or pyrimido [5,4-b] quinoline-2,4,9(1H,3H,5H)-trione 11 (Scheme 2).
The product was assigned structure 10 on the basis of spectral data and the chemical transformations outlined below. Thus, its 1 H NMR spectrum revealed the presence of D 2 O-exchangeable protons at δ = 10.36, 10.53 and 11.95 ppm which are attributable to the three NH protons, 1-NH, 3-NH and 7-NH, respectively. Also, the structure assigned for compound 10 was fully supported by its 13 C NMR spectrium. Further confirmation of structure 10 was achieved via the synthesis of its ethylated derivative 12 via the reaction of 10 with ethyl iodide in DMF and in the presence of anhydrous potassium carbonate (Scheme 3).
A distinction between compounds 10 and 12 is clearly manifested in the spectroscopic data. For example, the 1 H NMR spectrum of compound 12 revealed no NH protons, and the presence of four ethyl groups indicated that the alkylation occurs at the N-1, N-3, N-7 and OH atoms. Furthermore, the structure assigned to 12 was fully supported by its mass spectrum, which showed a molecular formula C 28 H 35 N 3 O 4 (m/z = 477 (35 %) [M] + ). With these spectroscopic data the proposed structure of 10 is identified. The formation of 10 was rationalized in terms of the initial formation of the intermediate 8 [29] . A subsequent reaction at the nucleophilic carbon atom C-6 in 5-aminouracil (1) leads to the formation of intermediate 9, which was cyclized via loss of water to finally form pyrrolopyrimidine 10 (Scheme 2). The same product was obtained by refluxing 5-aminouracil (1), dimedone (2) and phenylglyoxal hydrate (7) in DMF for 10 h.
In addition, the structure of 10 was confirmed further by an alternative synthesis of its isomer 11 (Scheme 4). The reaction of phenylglyoxal hydrate (7) with enaminoketone 13 [16] in DMF under microwave irradiation at 160 • C for 20 min afforded 10-benzoyl-7,7-dimethyl-7,8-dihydropyrimido[5,4-b]-quinoline-2,4,9(1H,3H,6H)-trione (11) (Scheme 4). The structure of the product 11 was confirmed by elemental analysis and spectral data. The disappearance of signals for 10-H and 5-NH in the 1 H NMR spectrum indicated the formation of compound 11.
We also studied the alkylation of 11 with ethyl iodide. The reaction was carried out at r. t. in DMF and in the presence of anhydrous potassium carbonate to afford the ethylated derivative 15 (Scheme 4). The structure of the product 15 was established by elemental analysis and spectral data. Its IR spectrum revealed absorption bands around 1654 -1690 cm −1 , characteristic of a carbonyl function. The 1 H NMR spectrum revealed that the alkylation occurs at the N-1 and N-3 atoms. Thus, the 1 H NMR spectrum of compound 15 contained signals from the N 1 CH 2 (δ = 3.80) and N 3 CH 2 protons (δ = 4.00 ppm). Furthermore, the structure assigned to 15 was fully supported by its mass spectrum, which indicated the molecular formula
Further confirmation of structure 15 was obtained via the reaction of ethylated enaminoketone 16 [17] with 7 in DMF under controlled microwave heating (Scheme 4).
As an extension of our synthetic methodology, 5-aminouracil (1), phenylglyoxal hydrate (7) and barbituric acids 5a, b were also exposed to MW irradiation. The reaction proceeded similarly to give 17a b (Scheme 5). The proposed molecular structures of 17a, b are supported by elemental and spectral analyses. The fragmentation patterns of the mass spectra of 17a and 17b showed the molecular ion peaks [M] + at m/z = 369 (70 %) and 353 (25 %), respectively, in good agreement with the assigned structure. The IR, 1 H NMR as well as the 13 C NMR spectra agreed with the proposed structures 17a, b. For example, the 1 H NMR spectrum of 17a revealed five relatively sharp singlets at δ = 10.55, 10.69, 12.11, 12.13 and 12.26 ppm assigned to the five NH groups, in addition to the signals for the dimedone and phenyl protons. Moreover, the ethylated derivative 18 was obtained by reacting 17a with ethyl iodide in DMF and in the presence of anhydrous potassium carbonate (Scheme 5). The structure of 18 was confirmed by its elemental and spectral analyses, which showed the molecular ion peak [M] + at m/z = 509 (100 %). Also, the 1 H NMR spectrum of 18 displayed signals of five ethyl groups indicating that the alkylation occurred at the N-1, N-3, N-7, OH and SH atoms. The imide hydrogen atoms in thiobarbituric acid take part in tautomerism so that the alkylation of this compound leads to a mixture of N-and S-alkyl derivatives [30, 31] Experimental Section
General procedures
Melting points were measured with a Gallenkamp apparatus and are uncorrected. The reactions and purity were monitored by thin layer chromatography (TLC) on aluminum plates coated with silica gel with fluorescence indicator (Merck, 60 F 254 ) using CHCl 3 -CH 3 OH (10 : 5) as eluent. Microwave irradiation was carried out using the Milestone Start Labstation for microwave-enhanced chemistry. Infrared spectra were recorded in potassium bromide disks on a Jasco FT/IR-450 Plus infrared spectrophotometer. 1 H NMR and 13 C NMR spectra were recorded on a Bruker DPX spectrometer operating at 400 MHz for 1 H NMR and 100 MHz for 13 [17] were synthesized using the published procedures.
Preparation of 5-(2-hydroxy-4,4-dimethyl-6-oxocyclohex-1-en-1-yl)-6-phenyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione (10)
Method A: A mixture of 5-aminouracil (1) (0.127 g, 1 mmol), dimedone (2) (0.140 g, 1 mmol) and phenylglyoxal hydrate (7) (0.134 g, 1 mmol) in DMF (5 mL) was heated under reflux in a Milestone Microwave Labstation at 160 • C for 20 min. The solvent was evaporated under reduced pressure. The solid product was collected by filtration and recrystallized from ethanol; yield 76 %.
Method B: A solution of equimolar amounts of 1 (0.127 g, 1 mmol), 2 (0.140 g, 1 mmol) and 7 (0.134 g, 1 mmol) in DMF (10 mL) was refluxed for 10 h. Product 10 was isolated as described above; yield 70 %.
Pale 
Preparation of 5-(2-ethoxy-4,4-dimethyl-6-oxocyclohex-1-enyl)-1,3,7-triethyl-6-phenyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione (12)
Ethyl iodide (2.496 g, 16 mmol) was added to a mixture of 10 (0.73 g, 2 mmol) and anhydrous potassium carbonate (1.104 g, 8 mmol) in DMF (20 mL). The reaction mixture was stirred for 80 h at r. t. and then poured into cold water and extracted with carbon tetrachloride (3 × 20 mL). The combined organic extracts were washed with water and dried (anhydrous magnesium sulfate). After evaporation of some of the solvent (∼ 5 mL), petroleum ether (30 mL) was added, and the resulting precipitate was collected, dried and recrystallized from diphenylether-n-hexane to afford 12 (yield 50 % 
Preparation of 10-benzoyl-7,7-dimethyl-7,8-dihydropyrimido[5,4-b]quinoline-2,4,9(1H,3H,6H)trione (11)
A mixture of 5-((5,5-dimethyl-3-oxocyclohex-1-en-1-yl)-amino)pyrimidine-2,4(1H,3H)-dione (13) 10-benzoyl-1,3-diethyl-7,7-dimethyl-7,8 -dihydropyrimido [5,4-b] quinoline-2,4,9 (1H,3H,6H)-trione (15) Method A: Ethyl iodide (0.624 g, 4 mmol) was added to a mixture of 11 (0.363 g, 1 mmol) and anhydrous potassium carbonate (0.276 g, 2 mmol) in DMF (10 mL). The reaction mixture was stirred for 70 h at r. t. and then poured into cold water and extracted with chloroform (3 × 20 mL). The combined organic extracts were washed with water and dried (anhydrous magnesium sulfate). After evaporation of some of the solvent (∼ 10 mL), petroleum ether (40 mL) was added, and the resulting precipitate was collected, dried and recrystallized from petroleum ether-chloroform to give 14; yield 43 %. 
Preparation of

Preparation of 6-phenyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-diones (17a, b)
A solution of equimolar amounts of 1 (0.127 g, 1 mmol), 7 (0.134 g, 1 mmol) and thiobarbituric acid 5a (0.144 g, 1 mmol) and/or barbituric acid 5b (0.128 g, 1 mmol) in DMF (5 mL) was heated under reflux in a Milestone Microwave Labstation at 160 • C for 20 min. The solvent was evaporated under reduced pressure. The solid product was collected by filtration and crystallized from the appropriate solvent. [2,3d] Hydroxy-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl) -2-(ethylthio)-6-oxo-1,6-dihydro 
5-(6-Hydroxy-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-6-phenyl-1H-pyrrolo
5-(6-
Synthesis of 5-(4-ethoxy
